• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XACT CAROTID STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XACT CAROTID STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number UNK XACT
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Myocardial Infarction (1969); Tissue Damage (2104); Transient Ischemic Attack (2109); Stenosis (2263)
Event Date 01/01/2014
Event Type  Injury  
Manufacturer Narrative
Date of event: date is estimated.The udi is unknown as individual part and lot numbers were not provided.The device was not returned for analysis.The lot history record (lhr) for this product could not be reviewed because the product was not returned for evaluation and the lot number was not reported.In this case, there was no reported device malfunction associated with the xact.The reported patient effects of stenosis, vessel damage, myocardial infarction (mi), stroke, and transient ischemic attack (tia) are listed in the xact instructions for use as known possible adverse events that may be associated with carotid stents and embolic protection systems.Based on the case information, a conclusive cause for the reported patient effects of stenosis, vessel damage, mi, stroke, and tia, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.The patient effect of death referenced is being filed under a separate medwatch report number.Reported attached: ¿vascular quality initiative, medical device report prepared for abbott vascular, x.Act carotid stent system.¿.
 
Event Description
It was reported through a post-market clinical follow-up (pmcf) report that the xact carotid artery stent may be related to stroke, mi, access site complication, post-procedural tia, recurrent carotid restenosis, re-treatment (percutaneous and surgical), and death.A device malfunction was not reported.Specific patient information is documented as unknown.Details are provided in the attached pmcf report, vascular quality initiative, medical device report prepared for abbott vascular, x.Act carotid stent system.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XACT CAROTID STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key11135645
MDR Text Key225808200
Report Number2024168-2021-00245
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040038
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Reporter Occupation Physician
Type of Report Initial
Report Date 01/07/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/07/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK XACT
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/18/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
Patient Age70 YR
-
-